Fine Chemicals Division logo


Biocatalyst Capabilities

Johnson Matthey has extensive capabilities in biocatalysts with a broad range of proprietary enzymes for the effective synthesis of pharmaceuticals. Encompassing enzyme discovery, evolution and manufacture we can support your product development from clinical studies through to commercial launch.

Our enzymes cover a broad range of transformations for the development of efficient and sustainable processes, including: asymmetric ketone reduction, kinetic resolution via hydrolytic reactions, transamination, asymmetric ene reduction and alcohol dehydrogenation. For the full range of our enzyme products see our Catalysts offering.

Our biocatalysts expertise complements our wider chiral capabilities and chemo-catalyst technology offering. Used in combination our bio- and chemo catalysts capabilities provide a unique resource for the most effective routes to your complex APIs.